Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Villoglandular adenocarcinoma of the cervix: two new cases with morphological and molecular study.

Giordano G, D'Adda T, Gnetti L, Merisio C, Gabrielli M, Melpignano M.

Int J Gynecol Pathol. 2007 Apr;26(2):199-204.

PMID:
17413990
2.

Human papillomavirus-positive well-differentiated villoglandular adenocarcinoma of the uterine cervix: A case report and review of the literature.

Yamazawa K, Matsui H, Seki K, Mitsuhashi A, Kawamata Y, Shirasawa H, Sekiya S.

Gynecol Oncol. 2000 Jun;77(3):473-7. Review.

PMID:
10831364
4.

Endometrial mucinous microglandular adenocarcinoma: morphologic, immunohistochemical features, and emphasis in the human papillomavirus status.

Giordano G, D'Adda T, Gnetti L, Merisio C, Melpignano M.

Int J Gynecol Pathol. 2006 Jan;25(1):77-82.

PMID:
16306789
5.

Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.

Ronnett BM, Yemelyanova AV, Vang R, Gilks CB, Miller D, Gravitt PE, Kurman RJ.

Am J Surg Pathol. 2008 Dec;32(12):1835-53. doi: 10.1097/PAS.0b013e3181758831.

PMID:
18813124
6.

Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.

Chiesa-Vottero AG, Malpica A, Deavers MT, Broaddus R, Nuovo GJ, Silva EG.

Int J Gynecol Pathol. 2007 Jul;26(3):328-33.

PMID:
17581420
7.

No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.

Wentzensen N, du Bois A, Kommoss S, Pfisterer J, von Knebel Doeberitz M, Schmidt D, Kommoss F.

Int J Gynecol Pathol. 2008 Jan;27(1):18-23.

PMID:
18156969
8.

Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma.

Quint KD, de Koning MN, Geraets DT, Quint WG, Pirog EC.

Gynecol Oncol. 2009 Sep;114(3):390-4. doi: 10.1016/j.ygyno.2009.05.013. Epub 2009 Jun 5.

PMID:
19500822
9.

p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.

Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Judson K, Ronnett BM.

Am J Surg Pathol. 2007 May;31(5):653-63.

PMID:
17460447
10.

Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.

Yildiz IZ, Usubütün A, Firat P, Ayhan A, Küçükali T.

Pathol Res Pract. 2007;203(6):445-9. Epub 2007 May 31. Review.

PMID:
17543474
11.

Villoglandular papillary adenocarcinoma of the uterine cervix with immunohistochemical characteristics.

Polat A, Düsmez D, Pata O, Aydin O, Egilmez R.

J Exp Clin Cancer Res. 2002 Sep;21(3):425-7.

PMID:
12385589
12.
13.

Adenocarcinoma of the uterine cervix: prognostic significance of clinicopathologic parameters, flow cytometry analysis and HPV infection.

Dabić MM, Nola M, Tomicić I, Dotlić S, Petrovecki M, Jukić S.

Acta Obstet Gynecol Scand. 2008;87(3):366-72. doi: 10.1080/00016340801936560.

PMID:
18307079
14.

Comparison of the hybrid capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesions.

Kang WD, Kim CH, Cho MK, Kim JW, Kim YH, Choi HS, Kim SM.

Int J Gynecol Cancer. 2009 Jul;19(5):924-8. doi: 10.1111/IGC.0b013e3181a832a2.

PMID:
19574786
15.

Expression of p16INK4a and MIB-1 in relation to histopathology and HPV types in cervical adenocarcinoma.

Muller S, Flores-Staino C, Skyldberg B, Hellström AC, Johansson B, Hagmar B, Wallin KL, Andersson S.

Int J Oncol. 2008 Feb;32(2):333-40.

PMID:
18202755
16.

High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.

Ressler S, Scheiden R, Dreier K, Laich A, Müller-Holzner E, Pircher H, Morandell D, Stein I, Viertler HP, Santer FR, Widschwendter A, Even J, Jansen-Dürr P, Capesius C, Zwerschke W.

Clin Cancer Res. 2007 Dec 1;13(23):7067-72.

17.

Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection.

Nara M, Hashi A, Murata S, Kondo T, Yuminamochi T, Nakazawa K, Katoh R, Hoshi K.

Gynecol Oncol. 2007 Aug;106(2):289-98. Epub 2007 May 30.

PMID:
17540439
18.

The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome.

Kuo KT, Hsiao CH, Lin CH, Kuo LT, Huang SH, Lin MC.

Mod Pathol. 2008 Apr;21(4):376-86. doi: 10.1038/modpathol.3800979. Epub 2008 Jan 25.

19.

P16(INK4a) overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas.

Giordano G, Azzoni C, D'Adda T, Merisio C.

Pathol Res Pract. 2007;203(7):533-8. Epub 2007 May 10.

PMID:
17498885
20.

Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples.

Kwaśniewska A, Korobowicz E, Zdunek M, Skoczyński M, Kwaśniewski W, Daniłoś J, Goździcka-Józefiak A.

Eur J Gynaecol Oncol. 2009;30(1):65-70.

PMID:
19317260

Supplemental Content

Support Center